7/20/2023 | CV | Market Commentary: Convertible traders focus on high-liquidity names as initial earnings are announced
|
2/17/2023 | CV | Market Commentary: Illumina convertibles active; Nio softens; HubSpot, DraftKings gain post-earnings
|
2/12/2021 | CV | Market Commentary: Ligand volatile; HubSpot convertible notes soar on earnings; Twitter, Peloton improve
|
6/5/2020 | CV | HubSpot greenshoe lifts five-year convertible notes to $460 million
|
6/2/2020 | CV | Market Commentary: Splunk convertibles eyed; Livongo, HubSpot notes hit aftermarket, expand on debut
|
6/2/2020 | CVLM | HubSpot exchanges about $272 million of 0.25% convertibles due 2022
|
6/2/2020 | CV | Market Commentary: Morning Commentary: Splunk eyed; Livongo, HubSpot hit the aftermarket, expand on debut
|
6/2/2020 | CV | New Issue: HubSpot prices $400 million five-year convertible notes to yield 0.375%, up 32.5%
|
6/1/2020 | CV | Market Commentary: Splunk notes on deck; Livongo, HubSpot convertible offerings eyed; Bilibili tops par
|
6/1/2020 | CVLM | HubSpot may repurchase, exchange some 0.25% convertibles due 2022
|
6/1/2020 | CV | Market Commentary: Morning Commentary: Livongo, HubSpot convertible offerings eyed; Invacare exchanges
|
6/1/2020 | CV | HubSpot talks $400 million five-year convertible notes to yield 0.125%-0.625%, up 30%-35%
|
10/13/2017 | CV | Market Commentary: Caesars Entertainment, HubSpot convertibles weaken in trading; Ensco notes active
|
10/10/2017 | CV | Market Commentary: Morning Commentary: Convertibles mostly quiet; HubSpot dips; Ares notes, shares improve
|
7/20/2017 | CV | Market Commentary: Dermira active, steady; HubSpot trends up; Ensco drifts lower; Crown Castle deal eyed
|
5/12/2017 | CV | Market Commentary: Stanley Black & Decker notches strong debut; Dermira deal touted; Becton Dickinson does well
|
5/11/2017 | CV | Market Commentary: Primary sees deal flow of $3.15 billion; Becton prices; Dermira rises; Black & Decker on tap
|
5/10/2017 | CV | HubSpot greenshoe lifts 0.25% five-year convertibles to $400 million
|
5/5/2017 | CV | Market Commentary: AMAG deal comes upsized, cheap; HubSpot ‘aggressively priced’; Herbalife edges higher
|
5/5/2017 | CV | Market Commentary: Morning Commentary: AMAG Pharmaceuticals deal comes upsized, cheap; HubSpot prices rich
|
5/5/2017 | CV | New Issue: HubSpot sells upsized $350 million five-year convertibles to yield 0.25%, up 35%
|
5/4/2017 | CV | Market Commentary: Spirit Realty convertibles tumble on earnings miss; Lumentum trades higher on 3D hopes
|
5/3/2017 | CV | Market Commentary: AMAG, HubSpot add deals to calendar; Tesla drops ahead of earnings; Akamai trades off
|
5/3/2017 | CV | HubSpot to price $300 million five-year convertible notes at 0.5%-1% yield, up 30%-35%
|